antibiotic pressure and resistance in bacteria sarmistha b. hauger m.d. director, pediatric...
TRANSCRIPT
![Page 1: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/1.jpg)
Antibiotic Pressure and Resistance in Bacteria
Sarmistha B. Hauger M.D.Director, Pediatric Infectious Disease
Children’s Hospital of AustinAustin, Texas
TDH CA-MRSA Conference
September, 2004
![Page 2: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/2.jpg)
Antibiotic Pressure and Resistance in Bacteria
• What is it and why is it important?
• How extensive is it?
• How does it happen?
• What factors promote the spread of resistant bacteria ?
• How does it pertain to the development of CA-MRSA infections?
• What can HCW do to curb this trend?
![Page 3: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/3.jpg)
Antibiotic Pressure and Resistance in Bacteria
What is it ? • ”Selection pressure of antibiotics has
led to the emergence of antibiotic-resistant bacteria.”
– Antibiotics can effect bacteria unrelated to the targeted infectious agent; these may be “normal” flora, leading to the emergence of resistant mutants inhabiting the same environment.
Baquero et al., International Report 1996;23:819
![Page 4: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/4.jpg)
Antibiotic Pressure and Resistance in BacteriaWhy is it important?
• Antibiotic resistance has developed in almost all classes of bacteria of pathogenic potential.
• Resistance in organisms of low virulence can emerge as important pathogens.
• The development of resistant bacteria has driven pharmaceutical research to develop more potent, broad-spectrum antibiotics.
• Use of these in turn, has fueled the appearance of bacteria with newer modes of resistance.
![Page 5: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/5.jpg)
Antibiotic Pressure and Resistance in BacteriaWhy is it important?
• Infections with resistant bacteria occur in health care settings AND the community.
• Examples of hospital setting: MDR Gram neg, MRSA, VRE
• Examples of community : MRSA, PRSP, Pcn R Quin R N. gonorrhea, antibiotic resistant Salmonella and Shigella
![Page 6: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/6.jpg)
Emergence of Antibiotic-Resistant Bacteria
Cohen; Science 1992;257:1050
Gram-negative rods
Enterococcus sp.
N. gonorrhoeae
H. influenzae
M. catarrhalis
S. pneumoniae
1950 1960 1970 1980 1990
S aureus
Penicillin
Ampicillin
3rd gen Cephalosporins
Quinolones
![Page 7: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/7.jpg)
Percentage of Laboratory Isolates Resistant
to Antibiotics, Texas
05
101520253035
Vancomycin-resistant
EnterococcusSpecies
Penicillin-resistant
Streptococcuspneumoniae
199920002001
Perc
enta
ge
How extensive is the problem ?
![Page 8: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/8.jpg)
Scope of Problem:S. pneumoniae
• Most common cause of bactemia, bacterial pneumonia, meningitis, OM, sinusitis in childhood.
• Highest rates of invasive pneumococcal disease occur among young children, especially those aged <2 years
• US data: the seven most common serotypes isolated from the blood or CSF of children age <6 years account for 80% of disease
• Antimicrobial resistance is detected most frequently among these same serotypes.
• 1998 surveillance data from eight states: these serotypes accounted for 80% of penicillin-nonsusceptible isolates.
![Page 9: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/9.jpg)
Percentage of Invasive Pneumococcal Isolates Nonsusceptible to Penicillin, Selected States,1997
Per
cen
tage
CDC, MMWR 1999; 48(30):656-661
0
5
10
15
20
25
30
35
40
MD CA OR CT MN GA TN
Resistant
Intermediatesusceptibility
557 182178 603
435
843439
![Page 10: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/10.jpg)
Mechanisms of Bacterial Resistance : how DO they do it ??
![Page 11: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/11.jpg)
Antibiotic Pressure and Resistance in BacteriaHow does it occur?
• All antibiotics do NOT kill bacteria in the same way.
• Various classes of antibiotics work on different aspects of bacterial replication.
![Page 12: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/12.jpg)
Folic acid synthesis
ß-lactams & Glycopeptides (Vancomycin)
50 50 5030 30 30
DNA
mRNA
Ribosomes
PABA
DHFA
THFA
Cell wall synthesis
DNA gyrase
Quinolones
Protein synthesis inhibition
Protein synthesis inhibitionTetracyclines
Protein synthesis mistranslation
Macrolides & Lincomycins
Cohen. Science 1992; 257:1064
DNA-directed RNA polymerase
Rifampin
Aminoglycosides
Sulfonamides
Trimethoprim
![Page 13: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/13.jpg)
Antibiotic Pressure and Resistance in BacteriaHow does it happen ?
• Bacteria can become resistant as a result of genetic mutations; these can be transferred between bacteria and groups of bacteria.
• Under selective pressure of antibiotic exposure, these strains then proliferate.
![Page 14: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/14.jpg)
Antibiotic Pressure and Resistance in BacteriaWhat happened to S. aureus ?
• Can become Resistant to the B-lactam drugs (PCNs, Cephalosporins) by making a B-lactamase.
• In response to development of a drug that is stable to this mechanism (methicillin/oxacillin), S. aureus alters its binding site (PBP): Methicillin Resistant S. aureus (MRSA)
• In response to use of other types of antibx to combat MRSA: few strains now with decr. sens to vancomycin, clindamycin.
![Page 15: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/15.jpg)
Antibiotic Pressure and Resistance in BacteriaWhat happened to S. aureus ?
• Reports of increasing use of third gen cephalosporins and quinolones related to emergence of MRSA.
• Some data suggest that quinolones enhance expression of methicillin reistance in SA in vitro
• Outbreaks of MRSA have been reduced by curbing antibiotic use: esp cephalosporins
![Page 16: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/16.jpg)
Antibiotic Pressure and Resistance in Bacteria What factors promote their development and spread ?
Alteration of normal flora
Practices contributing to misuse of antibiotics
Settings that foster drug resistance
Failure to follow infection control principles
![Page 17: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/17.jpg)
Inappropriate specimen selection and collection
Inappropriate clinical tests
Failure to use stains/smears
Failure to use cultures and susceptibility tests
Practices Contributing to Misuse of Antibiotics
![Page 18: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/18.jpg)
Inappropriate specimen selection and collection
Inappropriate clinical tests
Failure to use stains/smears
Failure to use cultures and susceptibility tests
Practices Contributing to Misuse of Antibiotics
![Page 19: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/19.jpg)
Use of antibiotics with no clinical indication (eg, for viral infections)
Use of broad spectrum antibiotics when not indicated
Inappropriate choice of empiric antibiotics
Inappropriate Antibiotic Use
![Page 20: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/20.jpg)
Inappropriate dose - ineffective concentration of antibiotics at site of infection
Inappropriate route - ineffective concentration of antibiotics at site of infection
Inappropriate duration
Inappropriate Drug Regimen
![Page 21: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/21.jpg)
Settings that Foster Drug Resistance
Day-care centers
Long term care facilities
Homeless shelters
Jails
Community
![Page 22: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/22.jpg)
Hospital Intensive care units
Oncology units
Dialysis units
Rehab units
Transplant units
Burn units
Settings that Foster Drug Resistance
![Page 23: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/23.jpg)
Physicians Can Impact
Other cl inicians
Patients
Optimize patient evaluation Adopt judicious antibioticprescribing practicesImmunize patients
Optimize consultations with other cliniciansUse infection control measuresEducate others about judicious use of antibiotics
![Page 24: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/24.jpg)
Public campaign, physician education, and increased antibiotic cost
25
89 90 91 92 93 94 95 960
5
10
15
20
Stephenson, JAMA 1996;275:175
Controlling Pneumococcal Resistance-Iceland
% n
onsu
scep
tibl
e S
. pne
umon
iae
![Page 25: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/25.jpg)
Controlling Erythromycin Resistance in Group A Streptococci - Finland
Seppala, NEJM 1997;337:441
YearEry
thro
myc
in c
onsu
mpt
ion
(DD
D/1
000)
Eryth
romycin resistan
ce (%)
87 88 89 90 91 92 93 94 95 960
1
2
3
4
5
10
15
20
25
30
Erythromycin resistance
Erythromycin consumption
![Page 26: Antibiotic Pressure and Resistance in Bacteria Sarmistha B. Hauger M.D. Director, Pediatric Infectious Disease Childrens Hospital of Austin Austin, Texas](https://reader036.vdocuments.us/reader036/viewer/2022062318/55156828550346a1418b4d86/html5/thumbnails/26.jpg)
Antibiotic Pressure and Resistance in Bacteria: Conclusions
• Bacteria evolve resistance to antibiotics in response to environmental pressure exerted by the use of antibiotics.
• Many of these bacteria are significant pathogens.
• Our responsibility to our community is to use antibiotics prudently, for appropriate indications.